Showing results (351-360 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|August 20, 2025
Prognostic immunoinflammatory and transcriptomic profiles in patients with pleural mesothelioma undergoing immunotherapyGiulia Mazzaschi, Roberto Rosati, Simona D'Agnelli, et al.Immunotherapy|February 28, 2023
Antithymocyte globulin for aplastic anemia secondary to pembrolizumab: a case report and review of literatureCynthia Yeung, Nicole Relke, David Good, et al.Immunotherapy|February 28, 2023
Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapyMateus de Oliveira Taveira, Milton José de Barros E Silva, Paula Nicole Vieira Barbosa PintoImmunotherapy|February 28, 2023
Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysisXueyin Zhou, Jiasheng Cao, Win Topatana, et al.Immunotherapy|February 15, 2023
Real-world maintenance therapy and survival outcomes for pembrolizumab plus pemetrexed and platinum for non-small-cell lung cancer in USAHimani Aggarwal, KayOnda Bayo, Yimei Han, et al.Immunotherapy|December 10, 2025
Consequences of adverse events in cancer immunotherapy combinations - a comprehensive real-world analysisSiv Gyda Aanes, Carsten Nieder, David Westfall Bates, et al.Immunotherapy|August 3, 2012
Concurrent HER2 vaccination and inhibition of kinase activity: safety and immunogenicityHuguette AlbrechtImmunotherapy|August 3, 2012
Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIVDmytro A Butov, Yuri V Efremenko, Natalia D Prihoda, et al.Immunotherapy|September 6, 2012
Mechanisms of endogenous MHC class II presentation by tumor cellsJian-Guo ChaiImmunotherapy|September 6, 2012
Chemokine-based immunotherapy: delivery systems and combination therapiesElham Mohit, Sima RafatiPageof 188